Evaluation Of The Provision Of Single Use Citric Acid Sachets To ...

More documents

Recommendations

Info

25Glasgow 1990-94: implications for control and prevention of blood-borne viruses.”Addiction 95 (6): 931-940Imbert, E., C. Aznar., & R. Natar (1999). Lemon, Vinegar, Fungus and “Brown Sugar”: ANe w Challenge fo r Ha rm Red u ction . P re sen ta tion 10 th Inte rna tio nal Confe rence on theReduction of Drug Related Harm , GenevaISD (2001) Scottish Drugs Misuse Statistics Scotland. Information & Statistics Division.EdinburghKaplan, E. H. (1994). “A method for evaluating needle exchange programmes.” Statisticsin Medicine 13: 2179-2187Kaplan, E. H. (1995). “Probability models of needle exchange.” Operations Research 43:558-569King, L. A. (1997). “Drug content of powders and other illicit preparations in the UK.”Forensic Science Inte rna tiona l 85: 135-147Kipke, M. D., et al (1998). HIV prevention for adolescent IDUs at a storefront needleex cha nge program in Ho llywo od, C A. P rese nted a t 12 th World AIDS Conference, Geneva,SwizerlandLaw, M. G. (1999). “Modelling the hepatitis C epidemic in Australia.” Journal ofGastroenterology and Hepatology 14: 1100-1107Lazza rin, A., e t al (1985). “Pulmona ry ca ndidiasis in a he ro in addict: some remarks on itsaetiology and pathogenesis.” British Journal of Addiction 80: 103-104Lindesm ith Center (2001). Research Brief: Syringe Access. Drug Policy Foundation,SacramentoLurie, P., et al (1993). The Public Health Impact of Needle Exchange Programs in theUnited States and Abroad. Prepared for the Centers for Disease Control and Prevention.Washington DC.Lurie , P ., & E. Drucke r (1997). “An oppo rtunity lost: HIV infe ctio ns a sso cia ted with la ck ofa national needle-exchange programme in the USA.” Lancet 349: 604-608Lurie, P., T. S. Jones, & J. Foley (1998). “A sterile syringe for every drug user injection:ho w many inje ctions take pla ce annua lly, and ho w might pha rma cis ts contribute tosyringe distribution?” Journal of Acquired Immune Deficiency Syndromes and HumanRetrovirology 18 (Supp. 1): S45-S51MacDonald, M. A., et al (2000). “Hepatitis C virus antibody prevalence among injectingdrug users at selected needle and syringe exchange programs in Australia, 1995-1997.”Medical Journal Australia 172Na tio nal Centre fo r HIV Epidemio logy and C linical Resea rch (2000). HIV/AIDS, Hepa titis Cand Sexually Transmissible Infections in Australia, Annual Surveillance Report 2000.University of New South Wales, SydneyNIH Consensus Statement on Intervention to Prevent HIV Risk Behaviours (1997).Normand, J., D. Viahov, & E. Lincoln, eds (1995). Preventing HIV Transmission: Role ofSte rile Nee dles and Blea ch. Na tiona l Academ y P ress, Wa shington DC.
26O live r, K. J., S. R . Friedman, H. Ma yna rd, L. Ma gnuson, & D. C. Des Ja rla is (1992).“Impact of a needle exchange program on potentially infectious syringes in public places.”Journal of Acquired Immune Deficiency Syndromes 5: 380Paone, D. (1997). Presentation at New York Stateside HIV Conference. February 1997Paone, D., J. Clark, Q. Shi, D. Purchase, & D. C. Des Jarlais (1999). “Syringe exchange inthe United States, 1996: a national profile.” American Journal of Public Health 89 (1): 43-46Preston, A. & J. Derricott. (2002). Citric Briefing. Http://www.saferinjecting.org.Report from the NIH Consensus Development Conference. February 1997.Remis, R. S., et al (1998). “Enough sterile syringes to prevent HIV transmission amonginjection drug users in Montreal?” Journal of Acquired Immune Deficiency Syndromes andHuman Retrovirology 18 (Supp. 1): S57-S59Robert, K., Gilmour, R., & M. Johnston. (2002) “Evaluation of introduction of pre-packs attwo community pharmacies in Glasgow.” Report to Greater Glasgow Primary Care NHSTrust. December 2002Schecter, M., et al (1999). “Do needle exchange programs increase the spread of HIVinfection among drug users?” AIDS 13(6): F45-F51SCIEH (2002) Hepa titis C Surve illa nce in Sco tland. Http://www.sho w.sco t.nhs.uk /sciehScott, J., et al (2000). “Laboratory study of the effects of citric and ascorbic acids oninje ctio ns prepa re d with bro wn he ro in.” Inte rna tiona l Journa l o f Drug Po licy 11 (6): 417-422Spe rling, J., & T. S. Je nnings (1997). “Fo rmula ry co nside ra tions fo r se le ction of pro tea seinhibitors.” Pharmacy and Therapeutics 229-240Strathdee, S. A., et al (1997). “Needle exchange is not enough: lessons from theVancouver injecting drug use study.” AIDS 11:F59-F65Vogt, R. L., et al (1998). “Hawaii’s stateside syringe exchange program.” American Journalof Public Health 88: 1403-1404Watters, J. K., et al (1994). “Syringe and needle exchanges as HIV/AIDS prevention forinjection drug users." Journal of the American Medical Association 271: 115-120W ilk inson, M. (2001) The Ca ra van P ro je ct: Lo ndon Http://www.saferinjecting.org.Wolk, J., A. Wodak, J. Guinan, P. Macaskill, & J. M. Simpson (1990). “The effect of aneedle and syringe exchange on a methadone maintenance unit.” British Journal ofAddictions 85: 1445-1450
Page 1 and 2: Effective Interventions UnitEVALUAT
Page 3 and 4: iABSTRACTThree hundred and sixty in
Page 5 and 6: 2diagnosed cases of HIV infected in
Page 7 and 8: 4and is so ld in poo rly so luble b
Page 9 and 10: 6CHAPTER 2 METHODOLOGYAims & Object
Page 11 and 12: 8CHAPTER 3 RESULTSStudy Group Chara
Page 13 and 14: 10more than any other drug also inj
Page 15 and 16: 12Table 3.5. Reasons for using curr
Page 17 and 18: 14The next most common eye problem
Page 19 and 20: 16That’s what I learnt from my ma
Page 21 and 22: 18s imply re turn to the needle ex
Page 23 and 24: 20rise in the numbe r o f visits is
Page 25 and 26: 22proposed to amend the misuse of d
Page 27: 24the era of needle/syringe exchang
Page 31 and 32: APPENDIX B: Structured Questionnair
Page 33 and 34: US ING THE C ITRIC AC ID S ACHETS22
Page 35 and 36: 37. In the last 3 months, approxima
Page 37: APPENDIX D: C itric Acid SachetSour

Evaluation Of The Provision Of Single Use Citric Acid Sachets To ...

Create successful ePaper yourself

Delete template?

Save as template?